Elutia (ELUT) vs Metagenomi Therapeutics (MGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Elutia (ELUT) has outperformed Metagenomi Therapeutics (MGX) over the past year, losing 6.5% versus a loss of 66.6%. Metagenomi Therapeutics is the larger company by market cap ($37.5 million vs $36.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELUT | MGX |
|---|---|---|
| Share price | $0.8273 | $0.9932 |
| Market cap | $36.64M | $37.52M |
| 1-day change | +0.88% | +0.86% |
| YTD return | +18.34% | -39.22% |
| 1-year return | -6.49% | -66.62% |
| 5-year return | -84.95% | — |
| EPS (TTM) | $-0.64 | $-2.49 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.39 | $3.95 |
| 52-week low | $0.50 | $0.96 |
| Distance from 52-week high | -40.27% | -74.86% |
| Average volume | 184.45K | 155.71K |
| Shares outstanding | 44.29M | 37.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed MGX by 60.1 percentage points over the past year.
ELUT vs MGX FAQ
Which is bigger, Elutia or Metagenomi Therapeutics?
Metagenomi Therapeutics (MGX) is larger, with a market capitalization of $37.52M compared with $36.64M for Elutia (ELUT).
Which stock has performed better over the past year, ELUT or MGX?
ELUT returned -6.49% over the past 12 months, compared with -66.62% for MGX (price return, excluding dividends). Past performance does not predict future results.
Are Elutia and Metagenomi Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.